BRIM Biotechnology Total Liabilities

BRIM Biotechnology (6885.TWO) currently reports a total liabilities of $74M as of December 2025. That compares with $350M in the prior-year period — down 79.1% year over year. Use the charts on this page to explore BRIM Biotechnology's total liabilities history and peer comparisons.

BRIM Biotechnology's total liabilities decreased from $350M to $74M — a 79.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BRIM Biotechnology reported $74M in total liabilities as of December 2025. That compares with $350M in the prior-year period — down 79.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $74M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BRIM Biotechnology, and consider following 6885.TWO for alerts when major investors trade the stock.

BRIM Biotechnology is classified in the Healthcare sector. On total liabilities, it currently shows $74M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6885.TWO with unrelated industries.